Lymphocyte counts may predict a good response to mesenchymal stromal cells therapy in graft versus host disease patients.

PLoS One · 2019 · PMC6561566 · PMID 31188842

Europe PMC DOI

hedged sentence

0.0640

closest p · 1.3× alpha

0.0640

boldest claim

The sentences

only marginally significantP = 0.064so close (0.05 < p ≤ 0.1)

In addition, a higher proportion of B cells (CD19, Fig 1C ) was also found, however this result was only marginally significant (P = 0.064).

also in 5,072 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.